| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29760977475bdb9cdf2d0bd7d11a4d8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98296acdab27f07e4fbab09f7fe1edf2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6933 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c70f152d74b0f40db7e4322e194a593c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d003a76d98438fbecda7f8e6ad706ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95977cbf04c2fb72e436fe4d92aa5151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df52de46ed4c2f44dbb9f1f326e7c796 |
| publicationDate |
2008-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-0700203-A2 |
| titleOfInvention |
Sustained release, core-shell structure precipitated citokine bionanocomposit, a process for producing the same and use thereof |
| abstract |
The invention relates to a sustained drug release nanocomposite, comprising a) a charge carrying core of primary protein particles reversibly precipitated in an ionic procedure from solutions containing at least one cytokine drug and b) a polyelectrolyte shell comprised of 3 to 5 alternate layers of two oppositely charged polyelectrolytes, the dissociation state of one of the polyelectrolytes being varied with pH of the aqueous medium while the other polyelectrolyte is fully dissociated, irrespective of the pH of the medium. There is also provided a process for producing the said nanocomposite and the use of the same for producing sustained release drug formulations. |
| priorityDate |
2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |